NETTWORK HOLDINGS
Nettwork Holdings is a distribution focused company that supports commercialization efforts across the healthcare ecosystem.
Ansella Therapeutics
Ansella Therapeutics is specialty pharmaceutical company that leverages biomimetic sciences to develop novel therapeutics that improve healthcare outcomes. The company’s initial focus is on women’s health, specifically in the development of novel vaginal formulations.
Avive Solutions
Avive is a MedTech company that has developed a next-generation automated external defibrillator (AED) and software solutions that revolutionizes the current sudden cardiac arrest (SCA) response.
Endeavor Biomedicines
Endeavor’s ENV-101 is a second-generation Hedgehog inhibitor with a highly favorable efficacy and side-effect profile compared to the molecules currently in the market. ENV-101 inhibits target pathway by ~90% at all tested doses.
Enquyst Technologies
Enquyst Technologies is developing the next-generation biopharmaceutical manufacturing platform which aims to redesign the downstream bioprocess equipment to bring unprecedented advantages in cost, time, footprint, and speed to market at commercial scale.
